Federated Hermes’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-584
| Closed | -$16.9K | – | 2117 |
|
|
2024
Q2 | $16.9K | Buy |
584
+49
| +9% | +$1.42K | ﹤0.01% | 1730 |
|
|
2024
Q1 | $23.9K | Sell |
535
-231
| -30% | -$10.3K | ﹤0.01% | 1707 |
|
|
2023
Q4 | $29.7K | Buy |
766
+121
| +19% | +$4.69K | ﹤0.01% | 1708 |
|
|
2023
Q3 | $19K | Sell |
645
-47
| -7% | -$1.38K | ﹤0.01% | 1769 |
|
|
2023
Q2 | $44K | Buy |
+692
| New | +$44K | ﹤0.01% | 1691 |
|
|
2023
Q1 | – | Sell |
-25,660
| Closed | -$1.78M | – | 2203 |
|
|
2022
Q4 | $1.78M | Hold |
25,660
| – | – | ﹤0.01% | 947 |
|
|
2022
Q3 | $3.76M | Hold |
25,660
| – | – | 0.01% | 736 |
|
|
2022
Q2 | $3.35M | Hold |
25,660
| – | – | 0.01% | 791 |
|
|
2022
Q1 | $2.59M | Buy |
25,660
+15,385
| +150% | +$1.55M | 0.01% | 960 |
|
|
2021
Q4 | $1.59M | Sell |
10,275
-15,675
| -60% | -$2.43M | ﹤0.01% | 1113 |
|
|
2021
Q3 | $7.68M | Sell |
25,950
-3,462
| -12% | -$1.02M | 0.01% | 714 |
|
|
2021
Q2 | $9.55M | Buy |
+29,412
| New | +$9.55M | 0.02% | 675 |
|